4.5 Review

Germline genetic factors in the pathogenesis of myeloproliferative neoplasms

Journal

BLOOD REVIEWS
Volume 42, Issue -, Pages -

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2020.100710

Keywords

Sporadic and familial MPN; Germline variants; Risk allele; SNV; CNV

Categories

Funding

  1. Institut National du Cancer (INCA PLBIO 2017)
  2. Association de recherche sur la moelle osseuse (ARMO)
  3. GIS-Institute for rare diseases for high throughput sequencing [AO9102LS]
  4. MPN research foundation
  5. Association pour la Recherche sur le Cancer
  6. Journees Nationales contre la leucemie (JNCL 2017)
  7. Labex GR-Ex - program Investissements d'avenir
  8. INCA-PLBIO 2017
  9. MENRT

Ask authors/readers for more resources

Myeloproliferative neoplasms (MPN) are clonal hematological malignancies that lead to overproduction of mature myeloid cells. They are due to acquired mutations in genes encoding for AK2, MPL and CALR that result in the activation of the cytokine receptor/JAK2 signaling pathway. In addition, it exists germline variants that can favor the initiation of the disease or may affect its phenotype. First, they can be common risk alleles, which correspond to frequent single nucleotide variants present in control population and that contribute to the development of either sporadic or familial MPN. Second, some variants predispose to the onset of MPN with a higher penetrance and lead to familial clustering of MPN. Finally, some extremely rare genetic variants can induce MPN-like hereditary disease. We will review these different subtypes of germline genetic variants and discuss how they impact the initiation and/or development of the MPN disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available